| 查看: 378 | 回复: 0 | |||
世外清风铁杆木虫 (职业作家)
|
[求助]
求翻译英语论文一段话(急),限今日,谢谢!
|
| Clinical composite tissue allotransplantation can adequately reconstruct defects that are not possible by other means. However, immunosuppressant toxicity limits the use of these techniques. Clinical attempts to reduce the amount of immunosuppression required by induction of an immunologically permissive state have so far been unsuccessful. The aim of this study was to induce tolerance in a preclinical large animal model. Donor hematopoietic stem cell (HSC) engraftment was induced by T-cell depletion, irradiation, and a short course of cyclosporine administered to the recipient, along with a hematopoietic cell infusion from a single haplotype major histocompatibility complex (MHC) mismatched donor. Skin was then allotransplanted from the donor. Both primarily vascularized skin flaps and secondarily vascularized conventional skin grafts were allotransplanted to investigate if the mode of transplantation affected outcome. Control animals received the skin allotransplants without conditioning. Tolerance was defined as no evidence of rejection at 90 days following transplantation. Conventional skin grafts only achieved prolonged survival (<65 days) in HSC-engrafted animals (P <0.01). In contrast, there was indefinite skin flap survival with the achievement of tolerance in HSC-engrafted animals; this was confirmed on histology with donor-specific unresponsiveness on MLR and CML. Furthermore, a conventional skin donor graft subsequently applied to an animal tolerant to a skin flap was not rejected and did not trigger skin flap rejection. To our knowledge, this is the first time skin tolerance has been achieved across a MHC barrier in a large animal model. This is a significant step toward thc goal of clinical skin tolerance induction. |
» 猜你喜欢
湖南大学刘巧玲课题组2026年第二批次博士研究生招生信息
已经有3人回复
通信工程求调剂!!!
已经有7人回复
26药学专硕105500求调剂
已经有8人回复
297,工科调剂?
已经有11人回复
申博自荐
已经有4人回复
294求调剂
已经有9人回复
289 分105500药学专硕求调剂(找B区学校)
已经有5人回复
291求调剂
已经有11人回复
304求调剂
已经有8人回复
求调剂推荐
已经有9人回复













回复此楼
20